IRIS
CELLERINO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.555
AS - Asia 905
NA - Nord America 694
SA - Sud America 75
AF - Africa 22
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.255
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 4.422
US - Stati Uniti d'America 648
SG - Singapore 355
CN - Cina 252
VN - Vietnam 155
BR - Brasile 47
BD - Bangladesh 40
FR - Francia 33
HK - Hong Kong 30
CA - Canada 22
DE - Germania 19
FI - Finlandia 18
GB - Regno Unito 15
IN - India 13
AR - Argentina 12
MX - Messico 12
IQ - Iraq 11
NL - Olanda 11
JP - Giappone 10
PK - Pakistan 9
RU - Federazione Russa 7
VE - Venezuela 7
MA - Marocco 6
PH - Filippine 6
PL - Polonia 6
EC - Ecuador 5
TN - Tunisia 5
TR - Turchia 5
ZA - Sudafrica 5
ID - Indonesia 4
JM - Giamaica 4
CH - Svizzera 3
ES - Italia 3
JO - Giordania 3
UA - Ucraina 3
AU - Australia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CO - Colombia 2
GR - Grecia 2
HT - Haiti 2
KE - Kenya 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BE - Belgio 1
BH - Bahrain 1
BW - Botswana 1
CL - Cile 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GT - Guatemala 1
IE - Irlanda 1
IR - Iran 1
KN - Saint Kitts e Nevis 1
LT - Lituania 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
SV - El Salvador 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 6.255
Salva come PNG Salva come JPEG
Città #
Genoa 2.348
Genova 911
Vado Ligure 615
Rapallo 389
Singapore 183
San Jose 169
Ashburn 132
Ho Chi Minh City 61
Beijing 58
New York 37
Hong Kong 30
Lauterbourg 29
Council Bluffs 28
Hanoi 23
Milan 23
Rome 19
Boardman 17
Helsinki 17
Frankfurt am Main 16
Los Angeles 14
Santa Clara 12
Turin 12
Bordighera 11
St Louis 11
Da Nang 9
Haiphong 9
Chicago 8
Mexico City 8
Montreal 8
Naples 8
Tokyo 8
Orem 7
Buffalo 6
Toronto 6
Atlanta 5
Dallas 5
Gainesville 5
Biên Hòa 4
Cardiff 4
Ninh Bình 4
Paris 4
Porto Alegre 4
São Paulo 4
Trento 4
Valenza 4
Amman 3
Baghdad 3
Boston 3
Can Tho 3
Caracas 3
Casablanca 3
Charlotte 3
Curitiba 3
Houston 3
Hải Dương 3
Johannesburg 3
Karbala 3
London 3
Quảng Ngãi 3
Rotterdam 3
Shenzhen 3
Thái Bình 3
Acalanes Ridge 2
Aurora 2
Baku 2
Belgrade 2
Brasília 2
Brescia 2
Bình Phước 2
Changsha 2
Chennai 2
Cincinnati 2
City of London 2
Erbil 2
Guayaquil 2
Kayseri 2
Kingston 2
Madrid 2
Marysville 2
Masłów 2
Mattarello 2
Miami 2
Nairobi 2
New Delhi 2
Parma 2
Perugia 2
Phủ Lý 2
Port-au-Prince 2
Rovereto 2
Rudolfstetten 2
San Antonio 2
Sarajevo 2
Thái Nguyên 2
Tianjin 2
Valguarnera Caropepe 2
Vercelli 2
Vĩnh Long 2
Warsaw 2
Abbeville 1
Abu Dhabi 1
Totale 5.414
Salva come PNG Salva come JPEG
Nome #
Different MRI patterns in MS worsening after stopping fingolimod 204
Osteopathic Manipulative Therapy and Multiple Sclerosis: A Proof-of-Concept Study 202
Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS 183
A novel prion protein gene-truncating mutation causing autonomic neuropathy and diarrhea 179
Levodopa-induced neutropenia. 171
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 165
Retinal degeneration in primary-progressive multiple sclerosis: A role for cortical lesions? 159
Corneal epithelial dendritic cells in patients with multiple sclerosis: An in vivo confocal microscopy study 158
Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population 151
Embracing resilience in multiple sclerosis: a new perspective from COVID-19 pandemic 140
Homonymous hemianopia as the first sign of posterior cortical atrophy 135
COVID-19 pandemic and mental distress in Multiple Sclerosis: implications for clinical management 135
Pediatric optic neuritis and anti MOG antibodies: a cohort of Italian patients 129
Impact of treatment on cellular immunophenotype in MS: A cross-sectional study 127
The early effect of cladribrine versus fingolimod on clinical and MRI measures in relapsing remitting multiple sclerosis 123
Assessing upper limb function in Multiple Sclerosis by an engineered glove 123
Central vein sign and diffusion MRI differentiate microstructural features within white matter lesions of multiple sclerosis patients with comorbidities 121
Risk of Persistent Disability in Patients with Pediatric-Onset Multiple Sclerosis 120
Clinical and radiological correlates of apathy in multiple sclerosis 117
On the Assessment of Gray Code Kernels for Motion Characterization in People with Multiple Sclerosis: A Preliminary Study 115
Cognitive changes in patients with relapse-free MS treated with high efficacy therapies: the predictive value of paramagnetic rim lesions 114
Corneal sub-basal nerve plexus analysis in patients with multiple sclerosis 111
Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational study 110
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis 110
CD19+ B cell values predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis 109
Multiscale networks in multiple sclerosis 108
Neuroaxonal Degeneration in Patients With Multiple Sclerosis: An Optical Coherence Tomography and in Vivo Corneal Confocal Microscopy Study 107
In-vivo characterization of macro- and microstructural injury of the subventricular zone in relapsing-remitting and progressive multiple sclerosis 106
EXPLORING THE INTERACTION BETWEEN FOCAL INFLAMMATION AND AXONAL INJURY IN MULTIPLE SCELROSIS: A NEW MECHANISM-DRIVEN FRAMEWORK TO MONITOR DISEASE ACTIVITY AND PROGRESSION 99
Tailoring B cell depletion therapy in MS according to memory B cell monitoring 97
Choroidal Thickness in Multiple Sclerosis: An Optical Coherence Tomography Study 97
Effect of ocrelizumab treatment on retinal atrophy: preliminary results from a single-center observational study 95
Safety of anti-varicella zoster virus vaccination in patients with multiple sclerosis treated with natalizumab: A case series 94
Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic? 92
Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis 90
Evaluating the central vein sign in paediatric-onset multiple sclerosis: A case series study 89
The effect of Cladribine and Fingolimod treatments on retinal atrophy 88
What happens after fingolimod discontinuation? A multicentre real-life experience 87
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial 84
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 80
Severe disease activity in MS patients treated with cladribine after fingolimod withdrawal 77
Brain lesion microstructure in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein disease 76
Predicting disease severity in Multiple Sclerosis using multimodal data and machine learning 75
Lesion phenotyping based on magnetic susceptibility in pediatric multiple sclerosis 74
Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study 74
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab 73
Erratum: Choroidal Thickness in Multiple Sclerosis: An Optical Coherence Tomography Study 69
The role of disconnection in explaining disability in multiple sclerosis 68
Physical exercise moderates the effects of disability on depression in people with multiple sclerosis during the covid-19 outbreak 60
Environmental risk factors for multiple sclerosis: a comprehensive systematic review and meta-analysis 57
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study 56
Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: A longitudinal multicenter study 55
Vaccinations in patients with multiple sclerosis: a real-world, single-center experience 53
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy 52
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 50
Relationship between ovarian reserve and disease activity in women with multiple sclerosis 49
ELEVATED RISK OF THROMBOTIC MANIFESTATIONS OF SARS-COV-2 INFECTION IN CANCER PATIENTS: A LITERATURE REVIEW 49
Vaccinations in patients with multiple sclerosis: a real-world, single-center, experience 48
Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors 43
The “central vein sign” to differentiate multiple sclerosis frommigraine 39
Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness z Scores 38
Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis 38
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 35
Childhood and Adolescent Environmental Risk Factors for Multiple Sclerosis: A Systematic Review With Meta-Analysis 29
Positioning siponimod and the post-treatment gap: the unmet needs of SPMS patients in Italian real-world practice 28
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study 24
First demyelinating attack in children: A twelve year single center cohort 24
Assessing Optic Nerve Involvement in Multiple SclerosisUsing Optical Coherence Tomography and Magnetic Resonance Imaging 23
Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis 22
Safety assessment of switching from fingolimod to siponimod: An Italian multicenter prospective study 22
null 20
Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing-Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter Study 10
Totale 6.434
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.928
article - articoli 22.824
book - libri 0
conference - conferenze 517
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 294
Totale 47.563
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/2022253 9 4 5 21 13 19 4 55 24 41 9 49
2022/2023469 34 44 11 51 52 62 4 33 77 4 77 20
2023/2024556 20 42 16 58 34 66 156 24 24 26 30 60
2024/20251.597 87 105 64 102 208 163 163 264 97 73 139 132
2025/20262.832 335 134 180 237 356 164 362 182 264 288 226 104
Totale 6.434